Inside these posts: Mitral regurgitation

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.

 

Study: Abbott heart-valve device safe, effective

Abbott's MitraClip. (Abbott)

Abbott Laboratories’ experimental device to repair leaky heart valves continues to show promise in patients two years after they have been treated, new research published in the New England Journal of Medicine today shows.

The MitraClip device, which is currently being review by the U.S. Food and Drug Administration for possible approval, is considered an important development for heart patients with mitral regurgitation because serious cases require open-heart surgery to repair their valves. It could be on the U.S. market by the end of this year. Get the full story »